Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 09:37AM EST. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.29B |
| Enterprise Value | 2.40B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 16.48 |
| Price/Book (mrq) | 3.65 |
| Enterprise Value/Revenue | 17.52 |
| Enterprise Value/EBITDA | -9.00 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.42 |
| 52-Week Change 3 | -58.12% |
| S&P500 52-Week Change 3 | -13.20% |
| 52 Week High 3 | 23.85 |
| 52 Week Low 3 | 3.85 |
| 50-Day Moving Average 3 | 7.71 |
| 200-Day Moving Average 3 | 7.16 |
Share Statistics
| Avg Vol (3 month) 3 | 5.92M |
| Avg Vol (10 day) 3 | 4.13M |
| Shares Outstanding 5 | 226.11M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 207.19M |
| % Held by Insiders 1 | 8.73% |
| % Held by Institutions 1 | 88.95% |
| Shares Short (Nov 14, 2022) 4 | 24.19M |
| Short Ratio (Nov 14, 2022) 4 | 3.38 |
| Short % of Float (Nov 14, 2022) 4 | 13.67% |
| Short % of Shares Outstanding (Nov 14, 2022) 4 | 10.70% |
| Shares Short (prior month Oct 13, 2022) 4 | 23.95M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Sept 29, 2022 |
Profitability
| Profit Margin | -218.44% |
| Operating Margin (ttm) | -208.41% |
Management Effectiveness
| Return on Assets (ttm) | -9.26% |
| Return on Equity (ttm) | -40.78% |
Income Statement
| Revenue (ttm) | 136.97M |
| Revenue Per Share (ttm) | 0.61 |
| Quarterly Revenue Growth (yoy) | -7.40% |
| Gross Profit (ttm) | 59.17M |
| EBITDA | -275.66M |
| Net Income Avi to Common (ttm) | -299.19M |
| Diluted EPS (ttm) | -0.83 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 834.34M |
| Total Cash Per Share (mrq) | 3.69 |
| Total Debt (mrq) | 948.3M |
| Total Debt/Equity (mrq) | 151.34 |
| Current Ratio (mrq) | 11.19 |
| Book Value Per Share (mrq) | 2.77 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -234.35M |
| Levered Free Cash Flow (ttm) | -110.17M |
© 2022 Yahoo. All rights reserved.
